Harvard Apparatus Regenerative Technology,
Why Robinhood?
You can watch HRGN and buy or sell other stocks, ETFs, and their options commission-free!About HRGN
Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.
HRGN Key Statistics
Stock Snapshot
As of today, Harvard Apparatus Regenerative Technology,(HRGN) shares are valued at $1.05. The company's market cap stands at 18.46M, with a P/E ratio of -2.60.
On 2026-07-25, Harvard Apparatus Regenerative Technology,(HRGN) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Harvard Apparatus Regenerative Technology,(HRGN) stock has reached 0, versus its average volume of 64.7.
The stock's 52-week range extends from a low of $0.96 to a high of $2.22.
The stock's 52-week range extends from a low of $0.96 to a high of $2.22.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.